Invitrocue

An innovative life sciences company that specialises in developing ground-breaking 3D cell-based models such as Patient-Derived Organoids from all solid cancers. By utilizing Onco-PDO test, we perform in vitro drug screenings on PDOs to provide the oncologists with the information to better direct patient therapy and personalized patient treatment. By enabling assessments of the best ways for drugs to be developed, we impart to the industry valuable knowledge in creating better, faster and more affordable disease treatments, working towards the companys goal of creating a healthier society by providing patients with the best possible care. Headquartered in Singapore and with...

Patient-derived organoids,contract research organization,onco-pdo test,personalized oncology,pdo-derived xenograft,pharmacology services,and safety assessment

Invitrocue operates in the Biotechnology research industry.

Invitrocue's revenue is 11m - 100m

Invitrocue has 11 - 50 employees.